ARDX insiders

22 insiders have filed at ARDX since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Mott David MDirector3.30M1.343%9 buys $8.7M
Raab MichaelPresident & CEO1.82M0.739%40 sells $5.1M
Rosenbaum David P.Chief Development Officer526.0k0.214%29 sells $1.9M
Rodriguez SusanChief Commercial Officer449.1k0.183%4 sells $150k
Williams Laura ASee Remarks436.1k0.177%19 sells $2.7M
Foster Eric DuaneChief Commercial Officer426.0k0.173%7 sells $194k
Rodgers Richard JDirector413.5k0.168%
Renz Justin AChief Financial Officer409.1k0.166%10 sells $1.7M
Kelliher MikeSee Remarks364.7k0.148%6 sells $178k
Bishop John ESee Remarks339.2k0.138%3 sells $19k
Blanks RobertSee Remarks314.4k0.128%7 sells $384k
Conner Edward R.Chief Medical Officer302.3k0.123%
Grammer Elizabeth ASee Remarks299.9k0.122%15 sells $4.2M
Bertrand William C JRDirector290.7k0.118%
Brady James ParkerChief Human Resources Officer262.9k0.107%2 sells $15k
Hohenleitner SusanChief Financial Officer230.5k0.094%2 sells $12k
Reilly Joseph JamesSee Remarks151.8k0.062%4 sells $91k
Cadoret-Manier OnaizaDirector151.7k0.062%
Bhanji MunaDirector137.4k0.056%
Felsch Robert OraSee Remarks91.6k0.037%7 sells $1.9M
Parsey MerdadDirector57.3k0.023%
Bazemore Robert BDirector41.6k0.017%

Full register at boothcheck.com/insiders/ARDX. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

ARDX institutional holders · ARDX research report